Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women

References

• Alexandraki, Irene, and Arshag D. Mooradian. 2010. “Barriers Related to Mammography Use for Breast Cancer Screening Among Minority Women.” Journal of the National Medical Association 102 (3): 206–218.
   PubMed Web of Science ®Google Scholar
• Antoniou, A. C., A. P. Cunningham, J. Peto, D. G. Evans, F. Lalloo, S. A. Narod, H. A. Risch, et al. 2008. “The BOADICEA Model of Genetic Susceptibility to Breast and Ovarian Cancers: Updates and Extensions.” British Journal of Cancer 98 (8): 1457–1466.
   PubMed Web of Science ®Google Scholar
• Antoniou, A. C., P. P. D. Pharoah, P. Smith, and D. F. Easton. 2004. “The BOADICEA Model of Genetic Susceptibility to Breast and Ovarian Cancer.” British Journal of Cancer 91 (8): 1580–1590. doi:10.1038/sj.bjc.6602175.
   PubMed Web of Science ®Google Scholar
• Armstrong, Katrina, Ellyn Micco, Amy Carney, Jill Stopfer, and Mary Putt. 2005. “Racial Differences in the Use of BRCA1/2 Testing Among Women with a Family History of Breast or Ovarian Cancer.” The Journal of the American Medical Association 293 (14): 1729–1736. doi:10.1001/jama.293.14.1729.
   PubMed Web of Science ®Google Scholar
• Bevers, Therese B., John H. Ward, Banu K. Arun, Graham A. Colditz, Kenneth H. Cowan, Mary B. Daly, Judy E. Garber, et al. 2016. “Breast Cancer Risk Reduction: NCCN Evidence Blocks, Version 1.2017.” December. https://www.nccn.org/professionals/physician_gls/pdf/breast_risk_blocks.pdf.
   Google Scholar
• Brown, Derek, Stephanie Shao, Ismail Jatoi, Craig D. Shriver, and Kangmin Zhu. 2016. “Trends in Use of Contralateral Prophylactic Mastectomy by Racial/Ethnic Group and ER/PR Status Among Patients with Breast Cancer: A SEER Population-Based Study.” Cancer Epidemiology 42 (June): 24–31. doi:10.1016/j.canep.2016.02.011.
   PubMedGoogle Scholar
• Claus, E. B., N. Risch, and W. D. Thompson. 1994. “Autosomal-Dominant Inheritance of Early-Onset Breast Cancer – Implications for Risk Protection.” Cancer 73 (3): 643–651.
   PubMed Web of Science ®Google Scholar
• Constantino, Joseph P., Mitchell H. Gail, David Pee, Stewart Anderson, Carol K. Redmond, Jacques Benichou, and H. Samuel Wieand. 1999. “Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence.” Journal of the National Cancer Institute 91 (18): 1541–1548.
   PubMedGoogle Scholar
• Cuzick, Jack, Ivana Sestak, Bernardo Bonanni, Joseph P. Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, et al. 2013. “Selective Oestrogen Receptor Modulators in Prevention of Breast Cancer: An Updated Meta-Analysis of Individual Participant Data.” The Lancet 381: 1827–1834.
   PubMed Web of Science ®Google Scholar
• Daly, Mary B., Robert Pilarski, Jennifer E. Axilbund, Michael Berry, Saundra S. Buys, Beth Crawford, Meagan Farmer, et al. 2016. “Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.” Journal of the National Comprehensive Cancer Network 14 (2): 153–162.
   PubMed Web of Science ®Google Scholar
• DeSantis, Carol E., Stacey A. Fedewa, Ann Goding Sauer, Joan L. Kramer, Robert A. Smith, and Ahmedin Jemal. 2016. “Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women.” CA: A Cancer Journal for Clinicians 66 (1): 31–42. doi:10.3322/caac.21320.
   PubMed Web of Science ®Google Scholar
• Domchek, Susan M., Tara M. Friebel, Christian F. Singer, Gareth Evans, Henry T. Lynch, Claudine Isaacs, Judy E. Garber, et al. 2010. “Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers with Cancer Risk and Mortality.” The Journal of the American Medical Association 304 (9): 967–975.
   PubMed Web of Science ®Google Scholar
• Eisen, Andrea, Jan Lubinski, Jan Klijn, Pal Moller, Henry T. Lynch, Kenneth Offit, Barbara Weber, et al. 2005. “Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23 (30): 7491–7496. doi:10.1200/JCO.2004.00.7138.
   PubMed Web of Science ®Google Scholar
• Eismann, Sabine, Lisa Vetter, Monika Keller, Thomas Bruckner, Michael Golatta, André Hennings, Christoph Domschke, et al. 2016. “Long-Term Experiences with Genetic Consultation in People with Hereditary Breast and Ovarian Cancer.” Archives of Gynecology and Obstetrics 294 (5): 1011–1018. doi:10.1007/s00404-016-4133-7.
   PubMed Web of Science ®Google Scholar
• Forman, Andrea D., and Michael J. Hall. 2009. “Influence of Race/Ethnicity on Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer.” The Breast Journal 15 (Suppl 1): S56–S62. doi:10.1111/j.1524-4741.2009.00798.x.
   PubMedGoogle Scholar
• Freedman, Andrew N., Barry I. Graubard, Sowmya R. Rao, Worta McCaskill-Stevens, Rachel Ballard-Barbash, and Mitchell H. Gail. 2003. “Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer Chemoprevention.” Journal of the National Cancer Institute 95 (7): 526–532.
   PubMedGoogle Scholar
• Friebel, Tara M., Susan M. Domchek, Susan L. Neuhausen, Theresa Wagner, D. Gareth Evans, Claudine Isaacs, Judy E. Garber, et al. 2007. “Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers.” Clinical Breast Cancer 7 (11): 875–882. doi:10.3816/CBC.2007.n.053.
   PubMed Web of Science ®Google Scholar
• Gail, M. H., L. A. Brinton, D. P. Byar, D. K. Corle, S. B. Green, C. Schairer, and J. J. Mulvihill. 1989. “Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually.” Journal of the National Cancer Institute 81: 1879–1886.
   PubMed Web of Science ®Google Scholar
• Gail, Mitchell H., and Phuong L. Mai. 2010. “Comparing Breast Cancer Risk Assessment Models.” Journal of the National Cancer Institute 102 (10): 665–668.
   PubMedGoogle Scholar
• Halbert, Chanita Hughes. 2006. “Genetic Counseling and Testing for Breast Cancer Risk in African Americans.” LDI Issue Brief 12 (1): 1–4.
   PubMedGoogle Scholar
• Hampel, Heather, K. Sweet, J. A. Westman, K. Offit, and C. Eng. 2004. “Referral for Cancer Genetics Consultation: A Review and Compilation of Risk Assessment Criteria.” Journal of Medical Genetics 41 (2): 81–91. doi:10.1136/jmg.2003.010918.
   PubMed Web of Science ®Google Scholar
• Iqbal, Javaid, Ophira Ginsburg, Paula A. Rochon, Ping Sun, and Steven A. Narod. 2015. “Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States.” The Journal of the American Medical Association 313 (2): 165–173. doi:10.1001/jama.2014.17322.
   PubMed Web of Science ®Google Scholar
• John, Esther M., Alexander Miron, Gail Gong, Amanda I. Phipps, Anna Felberg, Frederick P. Li, Dee W. West, and Alice S. Whittemore. 2007. “Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups.” The Journal of the American Medical Association 298 (24): 2869–2876. doi:10.1001/jama.298.24.2869.
   Web of Science ®Google Scholar
• Kaplan, Celia Patricia, Jennifer S. Haas, Eliseo J. Pérez-Stable, Steven E. Gregorich, Carol Somkin, Genevieve Des Jarlais, and Karla Kerlikowske. 2006. “Breast Cancer Risk Reduction Options: Awareness, Discussion, and Use among Women From Four Ethnic Groups.” Cancer Epidemiology and Prevention Biomarkers 15 (1): 162–166. doi:10.1158/1055-9965.EPI-04-0758.
   PubMed Web of Science ®Google Scholar
• Katapodi, Maria C., Kathy A. Lee, Noreen C. Facione, and Marylin J. Dodd. 2004. “Predictors of Perceived Breast Cancer Risk and the Relation Between Perceived Risk and Breast Cancer Screening: A Meta-Analytic Review.” Preventive Medicine 38 (4): 388–402. doi:10.1016/j.ypmed.2003.11.012.
   PubMed Web of Science ®Google Scholar
• Kim, Younji, Anne Marie McCarthy, Mirar Bristol, and Katrina Armstrong. 2017. “Disparities in Contralateral Prophylactic Mastectomy Use among Women with Early-Stage Breast Cancer.” NPJ Breast Cancer 3 (2). doi:10.1038/s41523-017-0004-z.
   Google Scholar
• Kolb, Bethany, Anne Marie Wallace, Deidre Hill, and Melanie Royce. 2006. “Disparities in Cancer Care Among Racial and Ethnic Minorities.” Oncology (Williston Park, N.Y.) 20 (10): 1256–1261; discussion 1261, 1265, 1268–1270.
   PubMedGoogle Scholar
• Kurian, Allison W. 2010. “BRCA1 and BRCA2 Mutations Across Race and Ethnicity: Distribution and Clinical Implications.” Current Opinion in Obstetrics and Gynecology 22: 72–78.
   PubMed Web of Science ®Google Scholar
• Lehman, Constance D., Claudine Isaacs, Mitchell D. Schnall, Etta D. Pisano, Susan M. Ascher, Paul T. Weatherall, David A. Bluemke, et al. 2007. “Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study.” Radiology 244 (2): 381–388. doi:10.1148/radiol.2442060461.
   PubMed Web of Science ®Google Scholar
• Lostumbo, L., N. E. Carbine, and J. Wallace. 2010. “Prophylactic Mastectomy for the Prevention of Breast Cancer (Review).” The Cochrane Collaboration 11: 1–91.
   Google Scholar
• Ludwig, Kandice K., Joan Neuner, Annabelle Butler, Jennifer L. Geurts, and Amanda L. Kong. 2016. “Risk Reduction and Survival Benefit of Prophylactic Surgery in BRCA Mutation Carriers, a Systematic Review.” American Journal of Surgery 212 (4): 660–669. doi:10.1016/j.amjsurg.2016.06.010.
   PubMed Web of Science ®Google Scholar
• MacNew, H. G., Ray Rudolph, S. T. Brower, A. N. Beck, and E. A. Meister. 2010. “Assessing the Knowledge and Attitudes Regarding Genetic Testing for Breast Cancer Risk in Our Region of Southeastern Georgia.” The Breast Journal 16 (2): 189–192. doi:10.1111/j.1524-4741.2009.00880.x.
   PubMed Web of Science ®Google Scholar
• Manning, Mark A., Neb Duric, Peter Littrup, Lisa Bey-Knight, Louis Penner, and Terrance L. Albrecht. 2013. “Knowledge of Breast Density and Awareness of Related Breast Cancer Risk.” Journal of Cancer Education: The Official Journal of the American Association for Cancer Education 28 (2): 270–274. doi:10.1007/s13187-013-0457-1.
   PubMed Web of Science ®Google Scholar
• Metcalfe, Kelly A., Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, et al. 2008a. “International Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers.” International Journal of Cancer 122 (9): 2017–2022.
   PubMed Web of Science ®Google Scholar
• Metcalfe, K. A., W. D. Foulkes, C. Kim-Sing, P. Ainsworth, B. Rosen, S. Armel, A. Poll, et al. 2008b. “Family Histoy as a Predictor of Uptake of Cancer Preventive Procedures by Women with a BRCA1 or BRCA2 Mutation.” Clinical Genetics 73 (5): 474–479.
   PubMed Web of Science ®Google Scholar
• Metcalfe, Kelly A., Nida Mian, Melissa Enmore, Aletta Poll, Marcia Llacuachaqui, Sonia Nanda, Ping Sun, Kevin S. Hughes, and Steven A. Narod. 2012. “Long-Term Follow-up of Jewish Women with a BRCA1 and BRCA2 Mutation Who Underwent Population Genetic Screening.” Breast Cancer Research and Treatment 133 (January): 735–740.
   PubMedGoogle Scholar
• Miles, Randy, Fei Wan, Tracy L. Onega, Amanda Lenderink-Carpenter, Ellen S. O’Meara, Weiwei Zhu, Louise M. Henderson, et al. 2018. “Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.” Journal of Women’s Health 27 (6): 748–754. doi:10.1089/jwh.2017.6623.
   PubMedGoogle Scholar
• Morgan, Debra, Heather Sylvester, F. Lee Lucas, and Susan Miesfeldt. 2009. “Cancer Prevention and Screening Practices among Women at Risk for Hereditary Breast and Ovarian Cancer After Genetic Counseling in the Community Setting.” Familial Cancer 8 (April): 277–287.
   PubMedGoogle Scholar
• National Cancer Institute. 2018. “High-Penetrance Breast and/or Gynecologic Cancer Susceptibility Genes.” PdqCancerInfoSummary. Genetics of Breast and Gynecological Cancer (PDQ®) – Health Professional Version, March 12. https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq#section/_88.
   Google Scholar
• Nelson, Heidi D., Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, and Rongwei Fu. 2014. “Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.” Annals of Internal Medicine 160 (4): 255–266. doi:10.7326/M13-1684.
   PubMed Web of Science ®Google Scholar
• Orom, Heather, Marc T. Kiviniemi, Vickie L. Shavers, Levi Ross, and Willie Underwood. 2013. “Perceived Risk for Breast Cancer and Its Relationship to Mammography in Blacks, Hispanics, and Whites.” Journal of Behavioral Medicine 36 (5): 466–476. doi:10.1007/s10865-012-9443-z.
   PubMed Web of Science ®Google Scholar
• Padamsee, Tasleem J., Anna Muraveva, Rachel Meadows, Megan Hils, Lisa D. Yee, Celia E. Wills, and Electra D. Paskett. “Racial Differences in Prevention Decision Making among Women at High Risk of Breast Cancer.” Under Review.
   Google Scholar
• Padamsee, Tasleem J., Anna Muraveva, Lisa D. Yee, Celia E. Wills, and Electra D. Paskett. 2017a. “Experiencing the Cancer of a Loved One Influences Decision-Making for Breast Cancer Prevention.” Journal of Health Psychology. Advance online publication. doi:10.1177/1359105317746480.
   PubMedGoogle Scholar
• Padamsee, Tasleem J., Celia E. Wills, Lisa D. Yee, and Electra D. Paskett. 2017b. “Decision Making for Breast Cancer Prevention among Women at Elevated Risk.” Breast Cancer Research 19 (34). doi:10.1186/s13058-017-0826-5.
   PubMedGoogle Scholar
• Richardson, Lisa C. 2016. “Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014.” MMWR. Morbidity and Mortality Weekly Report 65. doi:10.15585/mmwr.mm6540a1.
   Web of Science ®Google Scholar
• Sabatino, Susan A., Ellen P. McCarthy, Russell S. Phillips, and Risa B. Burns. 2007. “Breast Cancer Risk Assessment and Management in Primary Care: Provider Attitudes, Practices, and Barriers.” Cancer Detection and Prevention 31 (5): 375–383. doi:10.1016/j.cdp.2007.08.003.
   PubMedGoogle Scholar
• Schwartz, Marc D., Claudine Isaacs, Kristi D. Graves, Elizabeth Poggi, Beth N. Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L. Taylor, and Lauren Perley. 2012. “Long-Term Outcomes of BRCA1/BRCA2 Testing: Risk Reduction and Surveillance.” Cancer 118 (2): 510–517. doi:10.1002/cncr.26294.
   PubMed Web of Science ®Google Scholar
• Sherman, Kerry A., Suzanne M. Miller, Laura-Kate Shaw, Karen Cavanagh, and Sherri Sheinfeld Gorin. 2014. “Psychosocial Approaches to Participation in BRCA1/2 Genetic Risk Assessment Among African American Women: A Systematic Review.” Journal of Community Genetics 5 (2): 89–98. doi:10.1007/s12687-013-0164-y.
   PubMedGoogle Scholar
• Simon, Michael S., and Nancie Petrucelli. 2009. “Hereditary Breast and Ovarian Cancer Syndrome.” In Cancer Epidemiology, 487–500. Methods in Molecular Biology. Humana Press. doi:10.1007/978-1-59745-416-2_25.
   Google Scholar
• Skytte, A. B., A. M. Gerdes, M. K. Anderson, L. Sunde, K. Brondum-Nielsen, M. Waldstrom, S. Kolvraa, and D. Cruger. 2010. “Risk-Reducing Mastectomy and Salpingo-Oophorectomy in Unaffected BRCA Mutation Carriers: Uptake and Timing.” Clinical Genetics 77: 342–349.
   PubMed Web of Science ®Google Scholar
• Smith, S. G., I. Sestak, A. Forster, A. Partridge, L. Side, M. S. Wolf, R. Horne, J. Wardle, and J. Cuzick. 2016. “Factors Affecting Uptake and Adherence to Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis.” Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO 27 (4): 575–590. doi:10.1093/annonc/mdv590.
   PubMed Web of Science ®Google Scholar
• Tan, Yen Y., Leonie L. Noon, Julie M. McGaughran, Andreas Obermair, and Amanda B. Spurdle. 2013. “Referral of Patients with Suspected Hereditary Breast-Ovarian Cancer or Lynch Syndrome for Genetic Services: A Systematic Review.” Journal of Community Medicine & Health Education 3 (7). doi:10.4172/2161-0711.1000255.
   Google Scholar
• Tyrer, J., S. W. Duffy, and J. Cuzick. 2004. “A Breast Cancer Prediction Model Incorporating Familial and Personal Risk Factors.” Statistics in Medicine 23 (7): 1111–1130.
   PubMed Web of Science ®Google Scholar
• Warnecke, Richard B., April Oh, Nancy Breen, Sarah Gehlert, Electra Paskett, Katherine L. Tucker, Nicole Lurie, et al. 2008. “Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health Disparities.” American Journal of Public Health 98 (9): 1608–1615. doi:10.2105/AJPH.2006.102525.
   PubMed Web of Science ®Google Scholar
• Waters, Erika A., Kathleen A. Cronin, Barry I. Graubard, Paul K. Han, and Andrew N. Freedman. 2010. “Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women.” Cancer Epidemiology and Prevention Biomarkers 19 (2): 443–446. doi:10.1158/1055-9965.EPI-09-0930.
   PubMed Web of Science ®Google Scholar
• Wernli, Karen J., Wendy B. DeMartini, Laura Ichikawa, Constance D. Lehman, Tracy Onega, Karla Kerlikowske, Louise M. Henderson, et al. 2014. “Patterns of Breast Magnetic Resonance Imaging Use in Community Practice.” JAMA Internal Medicine 174 (1): 125–132. doi:10.1001/jamainternmed.2013.11963.
   PubMed Web of Science ®Google Scholar
• Williams, David R., and Pamela Braboy Jackson. 2005. “Social Sources of Racial Disparities in Health.” Health Affairs 24 (2): 325–334. doi:10.1377/hlthaff.24.2.325.
   PubMed Web of Science ®Google Scholar
• Williams, David R., and Selina A. Mohammed. 2009. “Discrimination and Racial Disparities in Health: Evidence and Needed Research.” Journal of Behavioral Medicine 32 (1): 20–47. doi:10.1007/s10865-008-9185-0.
   PubMed Web of Science ®Google Scholar
• Wong, Stephanie M., Rachel A. Freedman, Yasuaki Sagara, Fatih Aydogan, William T. Barry, and Mehra Golshan. 2017. “Growing Use of Contralateral Prophylactic Mastectomy Despite No Improvement in Long-Term Survival for Invasive Breast Cancer.” Annals of Surgery 265 (3): 581. doi:10.1097/SLA.0000000000001698.
   PubMed Web of Science ®Google Scholar
• Yeboa, Debra N., Xiao Xu, Beth A. Jones, Pamela Soulos, Cary Gross, and James B. Yu. 2016. “Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004–2009.” American Journal of Clinical Oncology 39 (6): 568–574. doi:10.1097/COC.0000000000000094.
   PubMed Web of Science ®Google Scholar